Jessica Weller, PA
Physician Assistant · Rogers, ARNPI 1699154567
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,410 of the $6,184 with a category attached, or 71.3%. 26 manufacturers reported payments, led by Medtronic at 44.8% of the total. Reporting peaked in 2022 at $2,075 and has fallen 77.2% since, to $473 in 2025. Among physician assistant clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 274 payments — averaging $22.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Novartis$803
- Pfizer$398
- Amgen$333
- Johnson & Johnson$303
- Merck$293
- plus $1K from 20 others
What the payments were for
- Travel & lodging$1,77529%
- Food & beverage$4,41071%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 43 | $2,771 |
| Novartis | 56 | $803 |
| Pfizer | 28 | $398 |
| Amgen | 23 | $333 |
| Johnson & Johnson | 34 | $303 |
| Merck | 18 | $293 |
| Amarin Pharma, Inc. | 12 | $249 |
| E.r. Squibb & Sons, L.L.C. | 14 | $202 |
| AstraZeneca | 9 | $128 |
| Kiniksa Pharmaceuticals, Ltd. | 5 | $89 |
| Abbott | 4 | $80 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $79 |
| Esperion Therapeutics, Inc. | 5 | $76 |
| Boehringer Ingelheim | 5 | $74 |
| Abiomed | 2 | $62 |
| Bayer | 3 | $47 |
| Edwards Lifesciences | 1 | $27 |
| Elutia, Inc. | 2 | $23 |
| Scpharmaceuticals Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Novo Nordisk | 1 | $21 |
| Boston Scientific | 1 | $19 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $18 |
| Bridgebio Pharma, Inc. | 1 | $17 |
| Lexicon Pharmaceuticals, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$1,860
How this compares
$6,184 in reported general payments places this provider in the 90th percentile of 451 physician assistant providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 142 | $152,309 |
| EntrestoSacubitril/Valsartan | 81 | $93,262 |
| XareltoRivaroxaban | 42 | $55,887 |
| JardianceEmpagliflozin | 42 | $42,889 |
| Repatha SureclickEvolocumab | 48 | $28,543 |
| FarxigaDapagliflozin Propanediol | 15 | $11,012 |
| Repatha SyringeEvolocumab | 12 | $6,639 |
| Metoprolol Succinate | 335 | $4,900 |
| Spironolactone | 346 | $1,816 |
| ClopidogrelClopidogrel Bisulfate | 184 | $1,706 |
| Atorvastatin Calcium | 153 | $1,331 |
| Ranolazine ErRanolazine | 11 | $1,192 |
| Carvedilol | 130 | $721 |
| Ezetimibe | 25 | $705 |
| Losartan Potassium | 91 | $666 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $398 | $152,309142 claims |
| NovartisEntresto | $803 | $93,26281 claims |
| Johnson & JohnsonXarelto | $303 | $55,88742 claims |
| Boehringer IngelheimJardiance | $74 | $42,88942 claims |
| AstraZenecaFarxiga | $128 | $11,01215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 451 physician assistant providers in Arkansas.
Other physician assistant in Rogers
- Adrienne EasterlingRogers$366K
- Honey SchaumburgFort Smith$397K
- Katherine RossLittle Rock$44K
- Benton LoggainsFort Smith$39K
- Monte DouglasJacksonville$38K
- Anna StilinovicFayetteville$32K
- Timothy BookerLittle Rock$13K
- Callie PooleJonesboro$12K
- Bryce BassFort Smith$11K
- Kayla MouryFort Smith$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.